Organovo Logo (2 Color Med-Res-082117).png
Organovo Achieves 3D Tissue Model for Crohn’s Disease
May 17, 2022 08:05 ET | Organovo, Inc.
SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional (3D) biology company focused on delivering scientific and medical breakthroughs using novel...
Global 3D Bioprinting Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
April 14, 2022 07:43 ET | Research and Markets
Dublin, April 14, 2022 (GLOBE NEWSWIRE) -- The "3D Bioprinting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Organovo Logo (2 Color Med-Res-082117).png
UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
March 01, 2022 08:05 ET | Organovo, Inc.
SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO (OTCPK: CLLKF, Nasdaq Stockholm: BICO.ST) announced they have reached agreement on a broad license for...
Organovo Logo (2 Color Med-Res-082117).png
Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
February 23, 2022 08:05 ET | Organovo, Inc.
SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO today announced they have reached agreement on a broad license for BICO and its affiliate companies to...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 18, 2022 16:00 ET | Organovo, Inc.
SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo”), today announced that it has granted a stock option to purchase 50,000 shares of common stock to one...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Welcomes New Sr. Vice President of Strategy and Business Development
February 18, 2022 13:00 ET | Organovo, Inc.
SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using 3D...
Vantage Market Research.png
The Future of Behavioral Mental Health Software Market Economy Size Expected a Growth of USD 5.20 Billion by 2028, According to Vantage Market Research
February 18, 2022 02:40 ET | Vantage Market Research
WASHINGTON, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Behavioral Mental Health Software Market finds that rising government funding & initiatives...
Organovo Logo (2 Color Med-Res-082117).png
Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents
February 02, 2022 12:00 ET | Organovo, Inc.
SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that two of its patents have withstood a patent challenge, and the company provided guidance on...
Vantage Market Research.png
Healthcare Asset Management Market to Reach $ 85,789.1 Million by 2028 - Increasing Need for Better Asset of Management is Driving the Healthcare Asset Management Market - Exclusive Report by Vantage Market Research
January 31, 2022 04:37 ET | Vantage Market Research
WASHINGTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Asset management is a systematic and cost-effective system of planning, acquiring, maintaining, operating, and disposing of the machinery, equipment,...
Vantage Market Research.png
3D Bioprinting Market Anticipated to Reach Over USD 1.8 Billion by 2028 – Exclusive Report by Vantage Market Research
January 26, 2022 22:48 ET | Vantage Market Research
WASHINGTON, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The Global 3D Bioprinting Market size is expected to reach over USD 1.8 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 13.6% during...